Givinostat conditionally approved to treat patients with Duchenne muscular dystrophy (DMD)

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (20 December 2024) granted a conditional marketing authorisation for the medicine givinostat (Duvyzat) to treat Duchenne muscular dystrophy (DMD).

Research: Drinking water quality in England, 2020 to 2022

Report on the quality of public water supplies and the largest private supplies that serve more than 5,000 consumers or exceed 1,000 cubic metres a day.

Research: EPR for packaging: updated illustrative base fees (December 2024)

Latest version of illustrative base fees for year 1 of extended producer responsibility (EPR) for packaging.

Policy paper: EPR for packaging: how local authority payments are calculated

Find out the methodology and procedure used to calculate payment estimates provided to Local Authorities (LAs) in November 2024.

November 2024 Transaction Data

This data provides information about the number and types of applications that HM Land Registry completed in November 2024.